Lipopolysaccharide augments IgG and IgE responses of mice to the latex allergen Hev b 5 - Journal of Allergy and Clinical Immunology
The low‐toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells - Thompson - 2005 - Journal of Leukocyte Biology - Wiley Online Library
Figure 7. Comparison of mono-phosphoryl lipid A and LPS structures. - Harnessing the Power of Microbes as Therapeutics: Bugs as Drugs - NCBI Bookshelf
Active center of LPS-based molecules with current or potential... | Download Scientific Diagram
Aluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release | The Journal of Immunology
Carbomer-based adjuvant elicits CD8 T-cell immunity by inducing a distinct metabolic state in cross-presenting dendritic cells | PLOS Pathogens
Bacterial Lipopolysaccharide as Adjuvants | SpringerLink
Modulating the innate immune response by combinatorial engineering of endotoxin | PNAS
Technology - Endotoxins, major bacterial antigen and powerful adjuvant
The Lipopolysaccharide Adjuvant Effect on T Cells Relies on Nonoverlapping Contributions from the MyD88 Pathway and CD11c+ Cells | The Journal of Immunology
Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy | Scientific Reports
TTLR4 agonists as effective vaccine adjuvants | Novel Immunologic Adjuvants
Lipopolysaccharide - Creative Biolabs
Correlates of GLA family adjuvants' activities - ScienceDirect
Frontiers | Lipopolysaccharide Derived From the Lymphoid-Resident Commensal Bacteria Alcaligenes faecalis Functions as an Effective Nasal Adjuvant to Augment IgA Antibody and Th17 Cell Responses | Immunology
Lipid A adjuvanted T cells in TRIF lps/lps recipients have impaired T... | Download Scientific Diagram
Frontiers | Mechanisms of Action of Adjuvants | Immunology
Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant. | Semantic Scholar
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients | Journal for ImmunoTherapy of Cancer | Full Text
Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen | Journal of Experimental Medicine | Rockefeller University Press
Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics - Chemical Science (RSC Publishing) DOI:10.1039/C7SC05323A
Predominant structures of the LPS preparations used as adjuvants. | Download Scientific Diagram
Development of adjuvant-combined vaccines for enhanced humoral and cellular immune responses - Australian Institute for Bioengineering and Nanotechnology - University of Queensland
Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants | PLOS ONE
TLR4 Agonists | LPS and Lipid A | InvivoGen
